tirzepatide and semaglutide peptide or small molecule primary structure. TZP is a 39-peptide containing different Glucagon‐like peptide‐1 and semaglutide. (a)

doi:10.1371/journal.pone.0108924

A similar beneficial association was seen in an observational study of semaglutide in 83,825 patients with obesity and 598,803 patients with T2DM over 12 months 112 , as well as in 87,676 new users of GLP-1RAs or DPP-4 inhibitors over 4 years 113

In addition to the elevated blood pressure readings obtained from the sphygmomanometer, patients with hypertension often experience other issues such as endothelial dysfunction, increased peripheral vascular resistance, and arterial stiffness

Lower blood pressure during weight loss and fluid shifts from nausea, vomiting, or poor intake can trigger reflex tachycardia